Suppr超能文献

微小RNA-203a通过靶向糖原合酶激酶-3β调控人肾细胞癌的增殖、迁移和凋亡。

miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.

作者信息

Hu Guanghui, Lai Peng, Liu Min, Xu Liang, Guo Zhuifeng, Liu Huan, Li Wei, Wang Gangchun, Yao Xudong, Zheng Junhua, Xu Yunfei

机构信息

Department of Urology, Shanghai Tenth People's Hospital, Tongji University, 301 Yanchang Road, Shanghai, 200072, China,

出版信息

Tumour Biol. 2014 Nov;35(11):11443-53. doi: 10.1007/s13277-014-2476-x. Epub 2014 Aug 15.

Abstract

MicroRNAs play a crucial role in cancer progression and metastasis. miR-203a has been identified as a tumor suppressor in various cancers. However, its functions in renal cell carcinoma have not been illustrated. In this study, we detected the miR-203a expression in renal cell carcinoma and evaluated its association with clinical features. Overexpression of miR-203a was found in renal cell carcinoma tissues and renal cell carcinoma cells. High miR-203a expression is correlated with tumor stage and short overall survival time. Bioinformatics and luciferase assay confirmed that glycogen synthase kinase-3β was a target gene of miR-203a. Silencing of miR-203a could inhibit cell proliferation and migration, arrest them in G1 phase, and promote apoptosis in vitro. miR-203a promotes the progression of renal cell carcinoma and predicts a poor prognosis.

摘要

微小RNA在癌症进展和转移中发挥着关键作用。miR-203a已被确定为多种癌症中的肿瘤抑制因子。然而,其在肾细胞癌中的功能尚未阐明。在本研究中,我们检测了肾细胞癌中miR-203a的表达,并评估了其与临床特征的关联。在肾细胞癌组织和肾细胞癌细胞中发现了miR-203a的过表达。高miR-203a表达与肿瘤分期和较短的总生存时间相关。生物信息学和荧光素酶测定证实糖原合酶激酶-3β是miR-203a的靶基因。沉默miR-203a可抑制细胞增殖和迁移,使它们停滞在G1期,并在体外促进细胞凋亡。miR-203a促进肾细胞癌的进展并预示预后不良。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验